Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer’s DiseaseShawn J. Stachel, John J. Renger, Jillian DiMuzio et al.|Journal of Medicinal Chemistry|2016Cited by 49
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitorsEdward J. Brnardic, Constantine Kreatsoulas, Robert B. Lobell et al.|Bioorganic & Medicinal Chemistry Letters|2007Cited by 44